Southern Star Research sold to investment firm
Southern Star Research has been advised by Gilbert + Tobin on all aspects of its sale to Quadrant Private Equity.
Firm: Gilbert + Tobin (Southern Star Research).
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: G+T has advised the founders of CRO Southern Star Research on its sale to Quadrant Private Equity’s Growth Fund.
Value: Undisclosed.
Area: M&A, finance.
Key players: The G+T team was led by corporate advisory partner David Josselsohn with support from lawyers Muli Zhou and Rohit Duggal. The corporate team was also supported by specialists throughout the firm.
Deal significance: Southern Star Research is a leading Australian full-service Contract Research Organisation (CRO) with a diverse client profile, ranging from large multinational pharmaceutical companies to smaller start-ups.
Mr Josselsohn commented: “We are pleased to have advised and supported the founders of Southern Star Research on this significant transaction for them and are excited to watch SSR’s growth under their partnership with Quadrant.”